Khurshid Khoja’s Post

View profile for Khurshid Khoja, graphic

Trailblazing Attorney | CEO, Greenbridge Corporate Counsel P.C. | VETS Policy Director | Chair Emeritus, NCIA Board | Business & Regulatory Law | Expert Witness on Cannabis & Psychedelics

The California Legislature just passed AB 2841, which allows the resumption of pre-clinical and clinical research on psychedelics and cannabis after it came to a screeching halt in 2023. Once the Governor signs the bill, it will go into effect immediately, allowing the Research Advisory Panel of California to begin clearing a backlog of nearly 70 study proposals that were still awaiting approval before the RAPC was prevented from meeting in closed session last year. While there is still much more work to be done in the legislature to expedite psychedelic research and advance the rapid development of psychedelic medicine in California, this is a victory well worth celebrating! #veterans #psychedelics #research #drugpolicy #cannabis #law

  • No alternative text description for this image
Belle Castro

California State Assembly Legislative Director

1w

Thank you for the help Khurshid! Glad we got it passed!

This is huge! I'm hoping this will spark even more conversation once the data starts rolling in.

Like
Reply

This is fantastic news for the future of psychedelic and cannabis research in California! A big win for science, innovation, and the potential benefits for mental health treatments. Kudos to everyone who worked hard to make this happen. Let’s keep the momentum going! 🚀👏

Dena Ladd, M.P.A.

Principal @ DSL Consulting Group | Founder WISER Women l MAC Women of Distinction l #healthadvocacy #researchadvocate #policy #emergingtherapies #mentalhealthadvocate

2d

Congratulations Khurshid Khoja. Great news

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics